Suppr超能文献

白细胞趋化因子2淀粉样变性(ALECT2)是埃及人中常见的一种肾淀粉样变性形式。

Leukocyte chemotactic factor 2 amyloidosis (ALECT2) is a common form of renal amyloidosis among Egyptians.

作者信息

Larsen Christopher P, Ismail Wesam, Kurtin Paul J, Vrana Julie A, Dasari Surendra, Nasr Samih H

机构信息

Nephropath, Little Rock, AR, USA.

Pathology Department, Beni-Suef University, Beni-Suef, Egypt.

出版信息

Mod Pathol. 2016 Apr;29(4):416-20. doi: 10.1038/modpathol.2016.29. Epub 2016 Feb 12.

Abstract

Large case series of renal amyloidosis subtypes have recently been published in the United States and Europe showing AL amyloidosis to be the predominant subtype in this part of the world. However, the most common subtypes of renal amyloidosis throughout the rest of the world are unknown. We present here the first large case series detailing the subtypes of renal amyloidosis among Egyptians. In this population, AA amyloidosis was the most common type of amyloidosis on renal biopsy at 48%. The newly described leukocyte chemotactic factor 2 amyloidosis (ALECT2) was the second most common type and represented nearly one-third of renal amyloid cases at 31%. AL accounted for only 20% of cases. The pathologic findings in ALECT2 cases were similar to those previously described in other case series. Thus ALECT2, which was initially thought to affect mainly Hispanics in the United States, appears to represent an important and likely underrecognized etiology of chronic kidney disease among Egyptians and probably in other ethnic groups around the world.

摘要

美国和欧洲最近发表了关于肾淀粉样变性亚型的大型病例系列研究,结果显示AL淀粉样变性是世界该地区的主要亚型。然而,世界其他地区肾淀粉样变性最常见的亚型尚不清楚。我们在此展示首个详细介绍埃及人肾淀粉样变性亚型的大型病例系列。在这一人群中,AA淀粉样变性是肾活检时最常见的淀粉样变性类型,占48%。新描述的白细胞趋化因子2淀粉样变性(ALECT2)是第二常见类型,占肾淀粉样病例的近三分之一,为31%。AL仅占病例的20%。ALECT2病例的病理表现与先前其他病例系列中描述的相似。因此,最初认为主要影响美国西班牙裔的ALECT2,似乎是埃及人以及世界其他种族慢性肾病的一个重要且可能未被充分认识的病因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb6a/5411489/8a7a28b76aa8/modpathol201629f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验